Rizobacter, a subsidiary of Bioceres Crop Solutions Corp. (NYSE:
BIOX) and global leader in sustainable solutions for agriculture,
and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an
international leader in sustainable bioprotection and plant health
solutions, announced the signing of an exclusive agreement to
distribute a foliar fertilizer and plant health technology in
Argentina, Uruguay, Paraguay and Bolivia.
South America is well-known for its extensive soybean, corn and
wheat production, crops where MBI’s technology will be an important
tool in helping growers increase yield through improved nutrition
and plant health. Demand for biologicals is increasing in the
region with an estimated market value of USD 1 billion and a
projected CAGR of 11%. Adoption of inoculants, biostimulants and
biopesticides is rapidly growing, driven by increased farmer
awareness and consumer demand for more environmentally sustainable
agricultural practices.
With 43 years of history and a renowned reputation in the South
American market, Rizobacter is well-placed to meet the increasing
biological demands of growers with this revolutionary plant health
product.
“Rizobacter has a strong focus in biologicals and sustainable
crop solutions. Our portfolio includes inoculants,
soil-applied specialty fertilizers and adjuvants for enhanced
foliar applications. This alliance enriches our offering of an
integrated crop nutrition program,” said Ricardo Yapur,
Rizobacter’s CEO.
"We are excited to partner with Rizobacter to introduce our
patented technology to the South American market,” said Matti
Tiainen, co-founder of Pro Farm, a wholly owned subsidiary of
Marrone Bio Innovations. “Rizobacter’s understanding of local
growers’ needs, strong distribution network and exceptional talent
make them an excellent partner that will allow us to bring
biological solutions to more farmers globally.”
The alliance between Rizobacter and Marrone Bio marries
complimentary portfolios and a strong commitment to research. The
result will provide farmers in Argentina, Uruguay, Paraguay and
Bolivia with a new solution that will add value to their farming
operations.
The product announcement and availability is expected in October
2020.
About RizobacterRizobacter, a subsidiary of
Bioceres Crop Solutions Corp. (NYSE: BIOX) is a leading company in
the development, manufacturing and commercialization of biological
solutions applied to agriculture. Rizobacter is delivering
state-of-the-art technologies in 31 countries through its eight
subsidiaries and highly-skilled distribution network. Rizobacter’s
main product lines are biologicals, adjuvants and specialty
fertilizers. Rizoliq TOP®, Osmium®, Signum®, Rizoliq LLI®,
Rizospray Extremo®, Rizospray Integrum® and Rizostar® are flagship
brands of Rizobacter.
For additional information, visit the company’s website at
www.rizobacter.com or follow on social media: Twitter, LinkedIn and
Instagram.
Rizobacter Contact: Pedro Mac Mullen, Marketing
Director pmacmullen@rizobacter.com.ar+54-2477-409400
About Marrone Bio Innovations Marrone Bio
Innovations Inc. (NASDAQ: MBII) is a growth-oriented company
leading the movement to a more sustainable world through the
discovery, development and sale of innovative biological products
for crop protection and plant health that help customers operate
more sustainably while increasing their return on investment. MBI
has screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies and natural product
chemistry to rapidly develop seven product lines. Supported by a
robust portfolio of over 400 issued and pending patents, MBI’s
currently available commercial products are Regalia®, Stargus®,
Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™,
Zelto® Jet-Oxide® and Jet-Ag® , with a
next-generation insecticide-nematicide, a breakthrough bioherbicide
and a biofumigant in the Company’s product pipeline. MBI’s Pro Farm
Finland-based subsidiary employs a proprietary technology derived
from wood waste to stimulate plant growth and improve plant health,
resulting in improved yields and crop quality. Products include
UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Learn more about Marrone Bio Innovations
at www.marronebio.com. We also use our investor relations
website, https://investors.marronebio.com, as well as our
corporate Twitter account, @Marronebio, as means of disclosing
material non-public information, and encourage our investors and
others to monitor and review the information we make public in
these locations. Follow us on social
media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company’s control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including, the
sales potential in South America, weather, the novel coronavirus
COVID-19, regulatory and other factors affecting demand for the
MBI’s products, any difficulty in marketing MBI’s products in its
target markets, competition in the market for pest management
products, lack of understanding of bio-based pest management
products by customers and growers. Additional information that
could lead to material changes in MBI’s performance is contained in
its filings with the SEC. MBI is under no obligation to, and
expressly disclaims any responsibility to, update or alter
forward-looking statements contained in this release, whether as a
result of current information, future events or otherwise.
Marrone Bio Innovations Contact:Kevin Hammill,
Chief Commercial Officerinfo@marronebio.com 1-530-750-2800
Investor Relations Contact:Greg Falesnik or
Luke ZimmermanMZ Group – MZ North AmericaPhone:
949-385-6449MBII@mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2024 to May 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From May 2023 to May 2024